| DIRECT COMPETITOR COMPARISON | |
| REGN | ABT | AMGN | Pvt1 | Industry | | Market Cap: | 2.11B | 82.52B | 56.92B | N/A | 107.08M | | Employees: | 967 | 72,000 | N/A | 11,1861 | 59 | | Qtrly Rev Growth (yoy): | 79.10% | 10.60% | 1.50% | N/A | 19.70% | | Revenue (ttm): | 338.30M | 30.77B | 14.64B | 13.42B1 | 13.84M | | Gross Margin (ttm): | -0.70% | 57.07% | 85.73% | N/A | 66.58% | | EBITDA (ttm): | -58.93M | 8.46B | 6.66B | N/A | -12.25M | | Oper Margins (ttm): | -20.95% | 20.82% | 38.31% | N/A | -158.08% | | Net Income (ttm): | -64.43M | 5.75B | 4.61B | 3.43B1 | N/A | | EPS (ttm): | -0.810 | 3.695 | 4.510 | N/A | -0.31 | | P/E (ttm): | N/A | 14.44 | 12.69 | N/A | 17.08 | | PEG (5 yr expected): | N/A | 1.03 | 1.27 | N/A | 1.15 | | P/S (ttm): | 6.13 | 2.68 | 3.90 | N/A | 9.82 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.21 | -0.44% | 56.92B | 12.69 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 54.09 | 2.37% | 15.64B | 18.10 | | Genzyme Corp. | GENZ | 54.87 | 0.70% | 14.56B | 31.28 | | Merck Serono S.A. | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.30 | 0.46% | 41.66B | 16.41 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 47.82 | 0.84% | 8.54B | 59.92 | | Teva Pharmaceutical Industries Limited | TEVA | 57.10 | 0.32% | 50.31B | 52.24 | | Sandoz International GmbH | Private - View Profile |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Watson Pharmaceuticals Inc. | WPI | 38.10 | 1.09% | 4.04B | 19.64 | | King Pharmaceuticals Inc. | KG | 11.44 | 1.24% | 2.84B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.68 | -0.45% | 5.40B | 108.47 | | Pfizer Inc. | PFE | 17.88 | 0.22% | 144.28B | 14.85 | | Johnson & Johnson | JNJ | 62.76 | 0.63% | 173.16B | 14.27 | | GlaxoSmithKline plc | GSK | 38.47 | 0.92% | 97.52B | 12.91 | | Sanofi-Aventis | SNY | 36.29 | 1.06% | 94.76B | N/A | | Novartis AG | NVS | 53.58 | 0.94% | 121.69B | 16.04 | | RHHBY.PK | 41.50 | 1.39% | N/A | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | AstraZeneca plc | AZN | 44.11 | 2.27% | 64.00B | 8.50 | | Abbott Laboratories | ABT | 53.35 | 0.00% | 82.52B | 14.44 | | Bristol-Myers Squibb Company | BMY | 24.25 | 1.21% | 48.04B | 4.51 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|